Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLoans and Notes ReceivablesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Gyre Therapeutics (GYRE) Shares Issued (2016 - 2025)

Historic Shares Issued for Gyre Therapeutics (GYRE) over the last 13 years, with Q3 2025 value amounting to $1.3 million.

  • Gyre Therapeutics' Shares Issued rose 24224.6% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 9237.06%. This contributed to the annual value of $1.9 million for FY2024, which is 2400.0% down from last year.
  • As of Q3 2025, Gyre Therapeutics' Shares Issued stood at $1.3 million, which was up 24224.6% from $1.0 million recorded in Q2 2025.
  • Gyre Therapeutics' 5-year Shares Issued high stood at $49.3 million for Q1 2021, and its period low was $275000.0 during Q2 2024.
  • For the 3-year period, Gyre Therapeutics' Shares Issued averaged around $6.8 million, with its median value being $807000.0 (2024).
  • Within the past 5 years, the most significant YoY rise in Gyre Therapeutics' Shares Issued was 27527.27% (2025), while the steepest drop was 4528.88% (2025).
  • Over the past 3 years, Gyre Therapeutics' Shares Issued (Quarter) stood at $49.3 million in 2021, then crashed by 98.8% to $593000.0 in 2024, then soared by 115.85% to $1.3 million in 2025.
  • Its Shares Issued stands at $1.3 million for Q3 2025, versus $1.0 million for Q2 2025 and $956000.0 for Q1 2025.